PatientsVille.com Logo

Raptiva Side Effects

PatientsVille

Common Raptiva Side Effects


The most commonly reported Raptiva side effects (click to view or check a box to report):

Psoriasis (216)
Headache (91)
Condition Aggravated (84)
Pyrexia (78)
Arthralgia (70)
White Blood Cell Count Increased (61)
Fatigue (42)
Influenza Like Illness (41)
Pain (39)
Oedema Peripheral (38)
Chills (36)
Rash (36)
Myalgia (35)
Nausea (33)
Dyspnoea (33)
Thrombocytopenia (32)
Back Pain (31)
Weight Decreased (31)
Infection (29)
Arthritis (29)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Raptiva Side Effects Reported to FDA



Raptiva Side Effect Report#8877679
Abdominal Tenderness, Chromaturia, Pneumonia, Skin Fissures, Rash Pustular
This is a report of a 40-year-old male patient (weight: NA) from US, suffering from the following health symptoms/conditions: psoriasis, who was treated with Raptiva (dosage: 0.8 Ml, Single, start time:
Jan 20, 2007), combined with: NA. and developed a serious reaction and side effect(s): Abdominal Tenderness, Chromaturia, Pneumonia, Skin Fissures, Rash Pustular after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Raptiva treatment in male patients, resulting in Abdominal Tenderness side effect. The patient was hospitalized.
Raptiva Side Effect Report#8875968
Hypernatraemia, Alanine Aminotransferase Increased, Condition Aggravated, Multiple Sclerosis
This report suggests a potential Raptiva Hypernatraemia side effect(s) that can have serious consequences. A 44-year-old male patient (weight: NA) from US was diagnosed with the following symptoms/conditions: pustular psoriasis and used Raptiva (dosage: NA) starting 200410. After starting Raptiva the patient began experiencing various side effects, including: Hypernatraemia, Alanine Aminotransferase Increased, Condition Aggravated, Multiple SclerosisAdditional drugs used concurrently: NA. Although Raptiva demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Hypernatraemia, may still occur.
Raptiva Side Effect Report#8875874
Muscle Spasms, Pain, Hyperaesthesia
This Muscle Spasms problem was reported by a physician from US. A female patient (weight: NA) was diagnosed with the following symptoms/conditions: psoriasis,pustular psoriasis. On 200508 this consumer started treatment with Raptiva (dosage: 1.4 Ml, 1/week). The following drugs were being taken at the same time: NA. When using Raptiva, the patient experienced the following unwanted symptoms/side effects: Muscle Spasms, Pain, HyperaesthesiaAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Muscle Spasms, may become evident only after a product is in use by the general population.
Raptiva Side Effect Report#8875860
Back Pain, Psoriasis, Pain In Extremity, Arthralgia, Arthralgia
This Back Pain side effect was reported by a consumer or non-health professional from US. A 37-year-old male patient (weight:NA) experienced the following symptoms/conditions: psoriasis,pustular psoriasis.The patient was prescribed Raptiva (drug dosage: 0.8 Ml, 1/week), which was initiated on
Apr 23, 2005. Concurrently used drugs: NA..After starting to take Raptiva the consumer reported adverse symptoms, such as: Back Pain, Psoriasis, Pain In Extremity, Arthralgia, ArthralgiaThese side effects may potentially be related to Raptiva.
Raptiva Side Effect Report#8875848
This is a report of a 66-year-old female patient (weight: NA) from US, suffering from the following health symptoms/conditions: psoriasis,pustular psoriasis, who was treated with Raptiva (dosage: NA, start time: NS), combined with: NA. and developed a serious reaction and side effect(s): after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Raptiva treatment in female patients, resulting in Death side effect.
Raptiva Side Effect Report#8875040
Accidental Overdose, Chills, Skin Exfoliation, Skin Fissures, Haemorrhage
This report suggests a potential Raptiva Accidental Overdose side effect(s) that can have serious consequences. A 49-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: psoriasis,pustular psoriasis and used Raptiva (dosage: 0.5 Ml, Single) starting
Jan 18, 2007. After starting Raptiva the patient began experiencing various side effects, including: Accidental Overdose, Chills, Skin Exfoliation, Skin Fissures, HaemorrhageAdditional drugs used concurrently: NA. Although Raptiva demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Accidental Overdose, may still occur.
Raptiva Side Effect Report#8874947
Psoriasis, Pruritus, Pain, Skin Exfoliation
This Psoriasis problem was reported by a physician from US. A female patient (weight: NA) was diagnosed with the following symptoms/conditions: psoriasis,pustular psoriasis. On
Jun 22, 2005 this consumer started treatment with Raptiva (dosage: 0.9 Ml, 1/week). The following drugs were being taken at the same time: NA. When using Raptiva, the patient experienced the following unwanted symptoms/side effects: Psoriasis, Pruritus, Pain, Skin ExfoliationAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Psoriasis, may become evident only after a product is in use by the general population.
Raptiva Side Effect Report#8874940
Thrombocytopenia, Pruritus, Pain
This Thrombocytopenia side effect was reported by a physician from US. A 46-year-old female patient (weight:NA) experienced the following symptoms/conditions: psoriasis,pustular psoriasis.The patient was prescribed Raptiva (drug dosage: 60 Mg, 1/week), which was initiated on
Jul 02, 2008. Concurrently used drugs: NA..After starting to take Raptiva the consumer reported adverse symptoms, such as: Thrombocytopenia, Pruritus, PainThese side effects may potentially be related to Raptiva. The patient was hospitalized.
Raptiva Side Effect Report#8874906
Myocardial Infarction, Rebound Psoriasis
This is a report of a male patient (weight: NA) from US, suffering from the following health symptoms/conditions: psoriasis,psoriatic arthropathy,pustular psoriasis, who was treated with Raptiva (dosage: 1.9 Ml, 1/week, start time: NS), combined with: NA. and developed a serious reaction and side effect(s): Myocardial Infarction, Rebound Psoriasis after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Raptiva treatment in male patients, resulting in Myocardial Infarction side effect. The patient was hospitalized.
Raptiva Side Effect Report#8874903
Psoriasis, Chapped Lips, Sunburn
This report suggests a potential Raptiva Psoriasis side effect(s) that can have serious consequences. A 63-year-old male patient (weight: NA) from US was diagnosed with the following symptoms/conditions: psoriasis and used Raptiva (dosage: 1.1 Ml, 1/week) starting
Apr 06, 2007. After starting Raptiva the patient began experiencing various side effects, including: Psoriasis, Chapped Lips, SunburnAdditional drugs used concurrently: NA. Although Raptiva demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Psoriasis, may still occur.
Raptiva Side Effect Report#8866277
Myalgia, Rash, Haemorrhage, Musculoskeletal Disorder
This Myalgia problem was reported by a consumer or non-health professional from US. A 58-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: psoriasis,pustular psoriasis. On
Sep 20, 2006 this consumer started treatment with Raptiva (dosage: 0.6 Unk, 1/week). The following drugs were being taken at the same time: NA. When using Raptiva, the patient experienced the following unwanted symptoms/side effects: Myalgia, Rash, Haemorrhage, Musculoskeletal DisorderAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Myalgia, may become evident only after a product is in use by the general population.
Raptiva Side Effect Report#8866198
Transient Ischaemic Attack, Asthma, Pain, Skin Exfoliation, Haemarthrosis, Skin Exfoliation, Hepatic Enzyme Increased, Erythema
This Transient Ischaemic Attack side effect was reported by a physician from US. A 48-year-old male patient (weight:NA) experienced the following symptoms/conditions: psoriasis,pustular psoriasis,asthma.The patient was prescribed Raptiva (drug dosage: 1 Mg, 1/week), which was initiated on
May 06, 2006. Concurrently used drugs: NA..After starting to take Raptiva the consumer reported adverse symptoms, such as: Transient Ischaemic Attack, Asthma, Pain, Skin Exfoliation, Haemarthrosis, Skin Exfoliation, Hepatic Enzyme Increased, ErythemaThese side effects may potentially be related to Raptiva. The patient was hospitalized and became disabled.
Raptiva Side Effect Report#8862203
Pancytopenia, Pyrexia, Lymphocytosis, Thrombocytopenia, Anaemia, Neutropenia, Skin Exfoliation
This is a report of a 35-year-old female patient (weight: NA) from Country Not Specified, suffering from the following health symptoms/conditions: psoriasis, who was treated with Raptiva (dosage: 70 Mg, 1/week, start time:
May 16, 2005), combined with: NA. and developed a serious reaction and side effect(s): Pancytopenia, Pyrexia, Lymphocytosis, Thrombocytopenia, Anaemia, Neutropenia, Skin Exfoliation after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Raptiva treatment in female patients, resulting in Pancytopenia side effect. The patient was hospitalized.
Raptiva Side Effect Report#8859516
Paraesthesia, Chills, Headache, Tenderness, Pruritus, Skin Plaque, Skin Exfoliation, Sleep Disorder
This report suggests a potential Raptiva Paraesthesia side effect(s) that can have serious consequences. A 39-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: psoriasis,pustular psoriasis and used Raptiva (dosage: .5 Ml, 1/week) starting
Aug 19, 2005. After starting Raptiva the patient began experiencing various side effects, including: Paraesthesia, Chills, Headache, Tenderness, Pruritus, Skin Plaque, Skin Exfoliation, Sleep DisorderAdditional drugs used concurrently: NA. Although Raptiva demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Paraesthesia, may still occur.
Raptiva Side Effect Report#8859504
Thrombocytopenia, Petechiae, Arthritis, Pain
This Thrombocytopenia problem was reported by a physician from US. A 66-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: psoriasis. On
Jun 22, 2005 this consumer started treatment with Raptiva (dosage: .5 Ml, Single). The following drugs were being taken at the same time: NA. When using Raptiva, the patient experienced the following unwanted symptoms/side effects: Thrombocytopenia, Petechiae, Arthritis, PainThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Thrombocytopenia, may become evident only after a product is in use by the general population.
Raptiva Side Effect Report#8859264
Pruritus, Chills, Nausea, Rash, Alopecia
This Death side effect was reported by a physician from US. A 55-year-old female patient (weight:NA) experienced the following symptoms/conditions: psoriasis,pustular psoriasis.The patient was prescribed Raptiva (drug dosage: NA), which was initiated on
Sep 07, 2007. Concurrently used drugs: NA..After starting to take Raptiva the consumer reported adverse symptoms, such as: Pruritus, Chills, Nausea, Rash, AlopeciaThese side effects may potentially be related to Raptiva.
Raptiva Side Effect Report#8858485
Influenza Like Illness, Pain, Chills, Pain, Pyrexia
This is a report of a 60-year-old female patient (weight: NA) from US, suffering from the following health symptoms/conditions: psoriasis, who was treated with Raptiva (dosage: NA, start time:
Feb 07, 2004), combined with: NA. and developed a serious reaction and side effect(s): Influenza Like Illness, Pain, Chills, Pain, Pyrexia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Raptiva treatment in female patients, resulting in Influenza Like Illness side effect.
Raptiva Side Effect Report#8857476
Influenza Like Illness, Headache, Injection Site Haemorrhage
This report suggests a potential Raptiva Influenza Like Illness side effect(s) that can have serious consequences. A 51-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: psoriasis and used Raptiva (dosage: .7 Mg/kg, Single) starting
Jan 12, 2004. After starting Raptiva the patient began experiencing various side effects, including: Influenza Like Illness, Headache, Injection Site HaemorrhageAdditional drugs used concurrently: NA. Although Raptiva demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Influenza Like Illness, may still occur.
Raptiva Side Effect Report#8857472
Pain, Psoriasis, Herpes Simplex, Pruritus
This Pain problem was reported by a physician from US. A 62-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: psoriasis,pustular psoriasis. On
Apr 30, 2006 this consumer started treatment with Raptiva (dosage: 90 Mg, 1/week, Conditioning Dose: 56 Mg). The following drugs were being taken at the same time: NA. When using Raptiva, the patient experienced the following unwanted symptoms/side effects: Pain, Psoriasis, Herpes Simplex, PruritusAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Pain, may become evident only after a product is in use by the general population.
Raptiva Side Effect Report#8857471
Lymphocyte Count Increased, Laryngitis, Skin Plaque, Anxiety
This Lymphocyte Count Increased side effect was reported by a physician from US. A female patient (weight:NA) experienced the following symptoms/conditions: psoriasis,pustular psoriasis.The patient was prescribed Raptiva (drug dosage: 0.8 Ml, Unk), which was initiated on NS. Concurrently used drugs: NA..After starting to take Raptiva the consumer reported adverse symptoms, such as: Lymphocyte Count Increased, Laryngitis, Skin Plaque, AnxietyThese side effects may potentially be related to Raptiva.
Raptiva Side Effect Report#8857465
Menstruation Irregular, Tooth Abscess, Pruritus, Skin Burning Sensation
This is a report of a female patient (weight: NA) from US, suffering from the following health symptoms/conditions: psoriasis,pustular psoriasis, who was treated with Raptiva (dosage: Conditining Dose 39.7 Mg, start time: 200506), combined with: NA. and developed a serious reaction and side effect(s): Menstruation Irregular, Tooth Abscess, Pruritus, Skin Burning Sensation after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Raptiva treatment in female patients, resulting in Death side effect.
Raptiva Side Effect Report#8857453
Influenza, Urticaria
This report suggests a potential Raptiva Influenza side effect(s) that can have serious consequences. A 78-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: psoriasis,psoriatic arthropathy and used Raptiva (dosage: 0.9 Ml, 1/week) starting
Nov 07, 2007. After starting Raptiva the patient began experiencing various side effects, including: Influenza, UrticariaAdditional drugs used concurrently: NA. Although Raptiva demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Influenza, may still occur.
Raptiva Side Effect Report#8853105
Exposure During Pregnancy
This Exposure During Pregnancy problem was reported by a physician from US. A female patient (weight: NA) was diagnosed with the following symptoms/conditions: psoriasis,pustular psoriasis. On
Mar 15, 2007 this consumer started treatment with Raptiva (dosage: 1.1 Ml, 1/week). The following drugs were being taken at the same time: NA. When using Raptiva, the patient experienced the following unwanted symptoms/side effects: Exposure During PregnancyAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Exposure During Pregnancy, may become evident only after a product is in use by the general population.
Raptiva Side Effect Report#8843645
Abdominal Pain Upper, Red Blood Cell Count Decreased, Pain In Extremity
This Abdominal Pain Upper side effect was reported by a physician from US. A female patient (weight:NA) experienced the following symptoms/conditions: psoriasis.The patient was prescribed Raptiva (drug dosage: 0.9 Ml, 1/week), which was initiated on
May 06, 2007. Concurrently used drugs:
  • Clarinex
  • Aciphex
.After starting to take Raptiva the consumer reported adverse symptoms, such as: Abdominal Pain Upper, Red Blood Cell Count Decreased, Pain In ExtremityThese side effects may potentially be related to Raptiva.
Raptiva Side Effect Report#8832328
Renal Failure Acute, Anaemia
This is a report of a 59-year-old female patient (weight: NA) from US, suffering from the following health symptoms/conditions: psoriasis, who was treated with Raptiva (dosage: 106 Mg, 1/week, start time: NS), combined with: NA. and developed a serious reaction and side effect(s): Renal Failure Acute, Anaemia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Raptiva treatment in female patients, resulting in Renal Failure Acute side effect. The patient was hospitalized.


1 of 64 


The appearance of Raptiva on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

What are common Raptiva Side Effects for Women?

Women Side EffectsReports
Psoriasis 113
Headache 46
Arthralgia 37
Pyrexia 35
Condition Aggravated 34
Fatigue 29
White Blood Cell Count Increased 29
Pain 27
Rash 21
Influenza Like Illness 20

What are common Raptiva Side Effects for Men?

Men Side EffectsReports
Psoriasis 102
Condition Aggravated 50
Headache 45
Pyrexia 43
Arthralgia 33
White Blood Cell Count Increased 32
Oedema Peripheral 23
Weight Decreased 23
Myalgia 21
Influenza Like Illness 20

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Raptiva reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Raptiva Side Effects

    Did You Have a Raptiva Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Raptiva for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Raptiva Safety Alerts, Active Ingredients, Usage Information

    More About Raptiva

    Side Effects reported to FDA: 1587

    Raptiva safety alerts: 2009 2008 2005

    Reported deaths: 114

    Reported hospitalizations: 679

    Raptiva (efalizumab) Feb 2009

    Audience: Dermatological healthcare professionals, patients 

    [UPDATE 04/08/2009] Genentech and FDA notified healthcare professionals of the voluntary, phased withdrawal of Raptiva, a medication for treatment of psoriasis, from the U.S. market due to a potential risk to patients of developing progressive multifocal leukoencephalopathy (PML). By June 8, 2009, Raptiva will no longer be available in the United States. Prescribers are being asked not to initiate Raptiva treatment for any new patients. Prescribers should immediately begin discussing with patients currently using Raptiva how to transition to alternative therapies. The FDA strongly recommends that patients work with their health care professional to transition to alternative therapies for psoriasis.

    [Posted 02/19/2009] FDA issued a Public Health Advisory to notify healthcare professionals of three confirmed, and one possible report of progressive multifocal leukoencephalopathy (PML), a rare brain infection, in patients using the psoriasis drug Raptiva. In October 2008, the labeling for Raptiva was changed to highlight, in a Boxed Warning, the risks of life-threatening infections, including PML. In addition, FDA directed Genentech, the manufacturer of Raptiva, to develop a Risk Evaluation and Mitigation Strategy, or REMS, to ensure that patients receive risk information about Raptiva. The FDA is reviewing this latest information. The agency will take appropriate steps to ensure that the risks of Raptiva do not outweigh its benefits, that patients prescribed Raptiva are clearly informed of the signs and symptoms of PML, and that health care professionals carefully monitor patients for the possible development of PML. The Public Health Advisory provides recommendations for healthcare providers and patients when treatment with this product is considered.

    [April 08, 2009 - Dear Healthcare Professional Letter - Genentech]
    [April 08, 2009 - Dear Patient Letter - Genentech]
    [April 08, 2009 - Statement - FDA]
    [February 19, 2009 - Public Health Advisory - FDA]
    [February 19, 2009 - News Release - FDA]

    Previous MedWatch Alert:

    [10/17/2008]

    Latest Raptiva clinical trials

    Raptiva Reviews

    No reviews, be a first to report a side effect via side effect reporting form